2011
DOI: 10.1016/j.intimp.2011.08.010
|View full text |Cite
|
Sign up to set email alerts
|

Toll-like receptors and diseases

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1

Citation Types

0
4
0

Year Published

2014
2014
2018
2018

Publication Types

Select...
3

Relationship

1
2

Authors

Journals

citations
Cited by 3 publications
(4 citation statements)
references
References 9 publications
0
4
0
Order By: Relevance
“…15,18,19 The activationof TLRs can recruit specific adaptors, such as MyD88, TRIF, and TRAM, to initiate the downstream signaling transduction and thus lead to the generation of inflammatory mediators involved in the pathogenesis of autoimmune diseases. 19,20 Given the pivotal role of TLRs in inflammation and autoimmunity, the identification of therapeutic targets of innate immunity with TLRs agonists and antagonists has sparked great interest. In our previous study, we have found that LPS/TLR4-mediated inflammation played an important role in RA pathogenesis, while IL-29 (IFN-λ1) could enhance LPS/TLR4-mediated inflammatory response by activating NF-κB and its downstream signaling pathway.…”
Section: Discussionmentioning
confidence: 99%
See 2 more Smart Citations
“…15,18,19 The activationof TLRs can recruit specific adaptors, such as MyD88, TRIF, and TRAM, to initiate the downstream signaling transduction and thus lead to the generation of inflammatory mediators involved in the pathogenesis of autoimmune diseases. 19,20 Given the pivotal role of TLRs in inflammation and autoimmunity, the identification of therapeutic targets of innate immunity with TLRs agonists and antagonists has sparked great interest. In our previous study, we have found that LPS/TLR4-mediated inflammation played an important role in RA pathogenesis, while IL-29 (IFN-λ1) could enhance LPS/TLR4-mediated inflammatory response by activating NF-κB and its downstream signaling pathway.…”
Section: Discussionmentioning
confidence: 99%
“…15,17 Accumulated evidence has strengthened the vital function of TLRs in the pathogenesis of autoimmune diseases, including RA, systemic lupus erythematosus, systemic sclerosis, Sjogren's syndrome. 15,18,19 The activationof TLRs can recruit specific adaptors, such as MyD88, TRIF, and TRAM, to initiate the downstream signaling transduction and thus lead to the generation of inflammatory mediators involved in the pathogenesis of autoimmune diseases. 19,20 Given the pivotal role of TLRs in inflammation and autoimmunity, the identification of therapeutic targets of innate immunity with TLRs agonists and antagonists has sparked great interest.…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…Toll-like receptors (TLRs) are a family of pattern-recognition receptors in the innate immune system. Exogenous and endogenous TLR ligands activate microglia that trigger inflammatory reactions in CNS ( 9 11 ). Recent studies using a mouse experimental brain abscess model have revealed a complex role for TLRs in the disease pathogenesis ( 12 ).…”
Section: Introductionmentioning
confidence: 99%